Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net earnings (loss)	$ 23,938	$ 323,442
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	26,929	26,955
Changes in fair value of interest rate swaps	(10,817)	(2,944)
Changes in fair value of contingent earn-out liability	(20,709)	71,954
Non-cash lease expense	1,169	1,429
Deferred income tax	(2,961)	(441,682)
Stock-based compensation expense	17,557	45,823
Net foreign exchange difference	(5,705)	(2,307)
Other, net	8,365	2,787
Changes in assets and liabilities:
Accounts receivable	494	(21,075)
Other current assets	(5,989)	(7,234)
Accounts payable	(10,355)	(9,194)
Deferred revenue	106	2,101
Legal liabilities	(750)	(30,243)
Accrued expenses and other current liabilities	(1,919)	(5,907)
Other, net	5	513
Net cash provided by (used in) operating activities	19,358	(45,582)
Cash flows from investing activities:
Capital expenditures	(4,996)	(2,712)
Acquisition of business, net of cash acquired	(69,720)	0
Other, net	0	(31)
Net cash used in investing activities	(74,716)	(2,743)
Cash flows from financing activities:
Proceeds from issuance of Class A common stock sold in initial public offering, net of offering costs	0	2,358,371
Payments to purchase and retire common stock	0	(1,018,365)
Purchase of Common Units from Pre-IPO Common Unitholders in the initial public offering	0	(973,289)
Withholding tax paid on behalf of employees on stock based awards	(5,708)	0
Repayment of term loan	(1,438)	(200,000)
Net cash provided by financing activities	(7,146)	166,717
Effects of exchange rate changes on cash and cash equivalents	2,117	(162)
Net increase (decrease) in cash and cash equivalents and restricted cash	(60,387)	118,230
Cash and cash equivalents and restricted cash, beginning of the period	369,175	128,029
Cash and cash equivalents and restricted cash, end of the period	308,788	246,259
Less restricted cash	0	257
Cash and cash equivalents, end of the period	$ 308,788	$ 246,002